Skip to main content
. 2021 May 11;13(10):2300. doi: 10.3390/cancers13102300
OC ovarian cancer
CA125 cancer antigen 125
RRSO risk-reducing bilateral salpingo-oophorectomy
RANK receptor activator of nuclear factor kappa-B
RANKL receptor activator of nuclear factor kappa-B ligand
LC-MS liquid chromatography-mass spectrometry
ELISA enzyme-linked immunosorbent assay
HP healthy participant
SD standard deviation
LC-MS/MS liquid chromatography-tandem mass spectrometry
DAP differential abundant protein
FDR false discovery rate
ROC receiver operating characteristic
AUC area under curve
GO gene ontology
ESI-LC-MS/MS electrospray ionization liquid chromatography–tandem mass spectrometry
MARS14 multiple Affinity Removal Column Human 14
ABC ammonium bicarbonate